Work

Abstract B31: A protein synthesis switch underlies initial survival of EGFR-mutant lung cancer to EGFR inhibitors

Year: 2018

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.aacriaslc18-b31

Authors: Kyung-A Song, Timothy L. Lochmann, Neha U. Patel, Jungoh Ham, Brad E. Windle, Hisashi Harada, Joel D. Leverson, Andrew J. Souers, Aaron N. Hata, Hiromichi Ebi, Anthony C. Faber

Institutions: Virginia Commonwealth University, AbbVie (United States), Massachusetts General Hospital, Kanazawa University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2945017306

Cites:

Cited by:

Related to: 10